Maravai LifeSciences Holdings, Inc. Class A Common Stock MRVI
Analyst Ratings
- Consensus
- Moderate Buy — 1 Buy · 1 Hold · 0 Sell (2 analysts)
- Avg. Price Target
- $7.25 (+6.8% upside)
Key Stats
- Today's Range
- $6.74 – $7.08
- 50-Day Range
- $5.41 – $9.42
- 52-Week Range
- $2.54 – $9.42
- Volume
- 2.24 million shs
- Average Volume
- 2.64 million shs
- Market Cap
- $1.01 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.42%
- Days to Cover
- 1.00
About Maravai LifeSciences Holdings, Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Related Stocks
Compare head-to-head: MRVI vs LLY·MRVI vs JNJ·MRVI vs ABBV·MRVI vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.